PHILAM LIFE TURNS OVER DONATION FOR CANCER REGISTRY

Philam Life, the country’s premier life insurance company, recently turned over a R1.5M donation to Cancer CARE Registry Philippines Foundation, Inc. (CARE Philippines), the first hospital-based cancer registry system in the country. This initiative was made possible through the Alliance for the Philippines’ Health and Advocacy (ALPHA), the healthbased consortium of Philam Life’s corporate social responsibility arm, Philam Foundation, together with the Philippine College of Surgeons and the Philippine College of Physicians.

The donation comes from a committed amount based on the sales of Active Joint Critical Protect, Philam Life’s landmark protection product, the first health and life insurance for two in the country which allows customers to safeguard themselves and a loved one against untoward events and critical illness. “This reflects our commitment to help address the protection gap in the country, one step in the fight against one of the top killer diseases in the country,” said Tennyson Paras, Philam Life Head of Products.

The web-based cancer registry system of CARE was created to collect and analyze data from Filipinos diagnosed with cancer from various public and private hospitals nationwide. The gathered data are analyzed and serves as a key driver for further research which can eventually influence patient care and protocol, public health policies, drug development, and other epidemiological research and activities.

“ALPHA has been making strides in the fight against cancer, with 20 hospital partners joining the program by the end of 2018. Its growth is a concrete manifestation of Philam Life’s serious intent to help Filipinos live healthier, longer and better lives,” said Max Ventura, President of Philam Foundation.

In photo: Tennyson Paras (right), Philam Life Head of Products, turns over the R1.5M check donation to Dra Beatrice Tiangco, CARE Philippines Co-Founder and Chief Executive Officer (center) and Max Ventura (left), Philam Foundation President.